All News
Filter News
Found 808,490 articles
-
Tivic Health Heads to American Academy of Otolaryngic Allergy and American Rhinologic Society Events in New Orleans, September 13-15
9/4/2019
Company to Demonstrate FDA Approved ClearUP Sinus Pain Relief
-
NorthSea Therapeutics Strengthens Its Management Team With the Appointment Of Mats Blom As CFO
9/4/2019
NorthSea Therapeutics B.V. announces the appointment of Mats Blom as Chief Financial Officer.
-
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
9/4/2019
Boehringer Ingelheim and Lupin Limited announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound as a potential targeted therapy for patients with difficult-to-treat cancers.
-
Summit Diagnostics Introduces Technology That Can Finally Shut Down Subversive Methods Like Synthetic Urine
9/4/2019
Summit Diagnostics now offers a new Validity Screen which now proves that the specimens being tested are real, unadulterated and not replaced with synthetics.
-
Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
9/4/2019
Achieve Life Sciences, Inc. announced that John Bencich, Chief Financial and Operating Officer, will present at two upcoming investor conferences.
-
APR Presents New Data at SSIEM Annual Symposium Showing Benefits of PKU GOLIKE® in PKU Management
9/4/2019
APR Applied Pharma Research s.a., the Swiss pharma company focused in specialized therapeutic areas and rare diseases, presents at the annual conference of SSIEM latest scientific data confirming benefits of PKU GOLIKE® in PKU management.
-
UrgentMED Network Expands to Two New Locations: Mar Vista Urgent Care and Long Beach Urgent Care
9/4/2019
Founded over a decade ago, UrgentMED Network launched with the primary goal of revolutionizing the healthcare industry.
-
Planmeca USA Launches Planmeca Viso™ G5 at ADA FDI 2019 World Dental Congress
9/4/2019
Planmeca USA, a leading manufacturer of dental imaging and CAD/CAM equipment, announces the launch of a new CBCT imaging unit at the ADA FDI 2019 World Dental Congress in San Francisco – the Planmeca Viso™ G5.
-
New report shows survival for blood cancers has increased more than any other cancer over 20 years
9/4/2019
Research is enabling precision medicine to change the future for an increasing number of Canadians facing blood cancer diagnoses
-
Hyundai Hope On Wheels Presents NYU School Of Medicine With $300,000 Hyundai Scholar Hope Grant To Support Pediatric Cancer Research
9/4/2019
The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research [04-September-2019] NEW YORK , Sept. 4, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announces $300
-
Magenta Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to MGTA-456 for the Treatment of Inherited Metabolic Disorders
9/4/2019
Magenta Therapeutics announced that the U.S. Food and Drug Administration granted Regenerative Medicine Advance Therapy designation for MGTA-456, a one-time cell therapy for the treatment of multiple inherited metabolic disorders.
-
Repare Therapeutics Announces US$82.5 Million Series B Financing
9/4/2019
Repare Therapeutics, a precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations, announced the completion of a US$82.5 million Series B financing.
-
MODAG Appoints Dr. Johannes Levin as Chief Medical Officer
9/4/2019
MODAG announced the appointment of Johannes Levin, M.D., as Chief Medical Officer.
-
Software Company, Eon, Introduces Initiative to Help Qualified Lung Cancer Screening Programs Across the United States Reach 100% CMS Compliance for Free
9/4/2019
This Fall Eon has made it their mission to travel the USA and provide a complete data debt analysis of all historical patient data submitted to CMS to any qualified hospital with an active lung cancer screening program.
-
Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer
9/4/2019
Beam Therapeutics announced the appointment of financial industry veteran, Terry-Ann Burrell, as chief financial officer.
-
Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS
9/4/2019
Genentech, a member of the Roche Group, announced that new data across its neuroscience portfolio will be presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis from September 11-13 in Stockholm.
-
BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs
9/4/2019
Bill & Melinda Gates Foundation invests $55 million in an infectious disease collaboration that could reach up to $100 million in total funding
-
Advancing Eyecare Announces Acquisition of Ophthalmic Instruments Inc.
9/4/2019
Acquisition of Ophthalmic Instruments Distributor Further Strengthens Advancing Eyecare's West Coast Presence
-
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
9/4/2019
NDA Submitted under the FDA’s Accelerated Approval Program
-
Nordic Nanovector to Participate in Three Upcoming Investor Conferences in the US
9/4/2019
Nordic Nanovector ASA announces that its CEO, Eduardo Bravo, will participate and present at the following upcoming investor conferences during September: